nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.666	1	CbGaD
Amitriptyline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.037	1	CbGbCtD
Amitriptyline—NTRK2—peripheral nervous system—amyotrophic lateral sclerosis	0.00544	0.0476	CbGeAlD
Amitriptyline—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0476	CcSEcCtD
Amitriptyline—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00454	0.0455	CcSEcCtD
Amitriptyline—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.00452	0.0396	CbGeAlD
Amitriptyline—NTRK2—nerve—amyotrophic lateral sclerosis	0.00424	0.0371	CbGeAlD
Amitriptyline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00324	0.0325	CcSEcCtD
Amitriptyline—NTRK2—hindbrain—amyotrophic lateral sclerosis	0.00318	0.0278	CbGeAlD
Amitriptyline—Mania—Riluzole—amyotrophic lateral sclerosis	0.00315	0.0316	CcSEcCtD
Amitriptyline—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0305	CcSEcCtD
Amitriptyline—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00299	0.03	CcSEcCtD
Amitriptyline—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0284	CcSEcCtD
Amitriptyline—KCNA1—nerve—amyotrophic lateral sclerosis	0.00246	0.0215	CbGeAlD
Amitriptyline—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.00245	0.0214	CbGeAlD
Amitriptyline—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0243	CcSEcCtD
Amitriptyline—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.00237	0.0208	CbGeAlD
Amitriptyline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0234	CcSEcCtD
Amitriptyline—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00229	0.023	CcSEcCtD
Amitriptyline—KCND2—hindbrain—amyotrophic lateral sclerosis	0.0021	0.0184	CbGeAlD
Amitriptyline—Coma—Riluzole—amyotrophic lateral sclerosis	0.00209	0.021	CcSEcCtD
Amitriptyline—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0199	CcSEcCtD
Amitriptyline—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.00189	0.0165	CbGeAlD
Amitriptyline—HTR7—pons—amyotrophic lateral sclerosis	0.00187	0.0163	CbGeAlD
Amitriptyline—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0186	CcSEcCtD
Amitriptyline—KCNA1—hindbrain—amyotrophic lateral sclerosis	0.00184	0.0161	CbGeAlD
Amitriptyline—KCND3—hindbrain—amyotrophic lateral sclerosis	0.00183	0.016	CbGeAlD
Amitriptyline—NTRK2—brainstem—amyotrophic lateral sclerosis	0.00182	0.0159	CbGeAlD
Amitriptyline—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00179	0.018	CcSEcCtD
Amitriptyline—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0173	CcSEcCtD
Amitriptyline—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0172	CcSEcCtD
Amitriptyline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0167	CcSEcCtD
Amitriptyline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0166	CcSEcCtD
Amitriptyline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0159	CcSEcCtD
Amitriptyline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0157	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0152	CcSEcCtD
Amitriptyline—OPRM1—nerve—amyotrophic lateral sclerosis	0.00137	0.012	CbGeAlD
Amitriptyline—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0137	CcSEcCtD
Amitriptyline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0133	CcSEcCtD
Amitriptyline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0133	CcSEcCtD
Amitriptyline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0131	CcSEcCtD
Amitriptyline—KCNQ2—brainstem—amyotrophic lateral sclerosis	0.00127	0.0111	CbGeAlD
Amitriptyline—NTRK2—medulla oblongata—amyotrophic lateral sclerosis	0.00127	0.0111	CbGeAlD
Amitriptyline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0127	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0126	CcSEcCtD
Amitriptyline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0126	CcSEcCtD
Amitriptyline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0125	CcSEcCtD
Amitriptyline—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0125	CcSEcCtD
Amitriptyline—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00124	0.0109	CbGeAlD
Amitriptyline—KCND2—brainstem—amyotrophic lateral sclerosis	0.0012	0.0105	CbGeAlD
Amitriptyline—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0012	0.012	CcSEcCtD
Amitriptyline—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00118	0.0103	CbGeAlD
Amitriptyline—HTR2A—pons—amyotrophic lateral sclerosis	0.00116	0.0102	CbGeAlD
Amitriptyline—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0115	CcSEcCtD
Amitriptyline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0115	CcSEcCtD
Amitriptyline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0115	CcSEcCtD
Amitriptyline—NTRK2—spinal cord—amyotrophic lateral sclerosis	0.00113	0.00991	CbGeAlD
Amitriptyline—KCNA1—brainstem—amyotrophic lateral sclerosis	0.00105	0.00923	CbGeAlD
Amitriptyline—KCND3—brainstem—amyotrophic lateral sclerosis	0.00105	0.00918	CbGeAlD
Amitriptyline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0103	CcSEcCtD
Amitriptyline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0102	CcSEcCtD
Amitriptyline—SLC6A2—nerve—amyotrophic lateral sclerosis	0.001	0.00879	CbGeAlD
Amitriptyline—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.000993	0.00869	CbGeAlD
Amitriptyline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000981	0.00984	CcSEcCtD
Amitriptyline—HTR7—nerve—amyotrophic lateral sclerosis	0.000969	0.00847	CbGeAlD
Amitriptyline—KCNQ3—medulla oblongata—amyotrophic lateral sclerosis	0.000963	0.00842	CbGeAlD
Amitriptyline—NTRK2—nervous system—amyotrophic lateral sclerosis	0.000955	0.00835	CbGeAlD
Amitriptyline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000939	0.00941	CcSEcCtD
Amitriptyline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00093	0.00932	CcSEcCtD
Amitriptyline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00923	CcSEcCtD
Amitriptyline—NTRK2—central nervous system—amyotrophic lateral sclerosis	0.000919	0.00804	CbGeAlD
Amitriptyline—DRD2—nerve—amyotrophic lateral sclerosis	0.000916	0.00801	CbGeAlD
Amitriptyline—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.000911	0.00797	CbGeAlD
Amitriptyline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00906	CcSEcCtD
Amitriptyline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00901	CcSEcCtD
Amitriptyline—NTRK2—cerebellum—amyotrophic lateral sclerosis	0.000898	0.00786	CbGeAlD
Amitriptyline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00899	CcSEcCtD
Amitriptyline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000885	0.00888	CcSEcCtD
Amitriptyline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00883	CcSEcCtD
Amitriptyline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000868	0.0087	CcSEcCtD
Amitriptyline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00867	CcSEcCtD
Amitriptyline—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.000855	0.00748	CbGeAlD
Amitriptyline—HTR2A—appendage—amyotrophic lateral sclerosis	0.000852	0.00745	CbGeAlD
Amitriptyline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00852	CcSEcCtD
Amitriptyline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000843	0.00845	CcSEcCtD
Amitriptyline—KCND2—medulla oblongata—amyotrophic lateral sclerosis	0.000839	0.00734	CbGeAlD
Amitriptyline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00837	CcSEcCtD
Amitriptyline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000825	0.00827	CcSEcCtD
Amitriptyline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000818	0.0082	CcSEcCtD
Amitriptyline—Shock—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00807	CcSEcCtD
Amitriptyline—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00803	CcSEcCtD
Amitriptyline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000798	0.008	CcSEcCtD
Amitriptyline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000791	0.00793	CcSEcCtD
Amitriptyline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00782	CcSEcCtD
Amitriptyline—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.000775	0.00678	CbGeAlD
Amitriptyline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000764	0.00766	CcSEcCtD
Amitriptyline—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.000759	0.00664	CbGeAlD
Amitriptyline—KCND2—spinal cord—amyotrophic lateral sclerosis	0.000748	0.00655	CbGeAlD
Amitriptyline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00742	CcSEcCtD
Amitriptyline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000734	0.00736	CcSEcCtD
Amitriptyline—NTRK2—brain—amyotrophic lateral sclerosis	0.00073	0.00638	CbGeAlD
Amitriptyline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000727	0.00729	CcSEcCtD
Amitriptyline—HTR7—hindbrain—amyotrophic lateral sclerosis	0.000725	0.00635	CbGeAlD
Amitriptyline—KCNQ3—nervous system—amyotrophic lateral sclerosis	0.000723	0.00633	CbGeAlD
Amitriptyline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00722	CcSEcCtD
Amitriptyline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000711	0.00713	CcSEcCtD
Amitriptyline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00707	CcSEcCtD
Amitriptyline—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0007	0.00612	CbGeAlD
Amitriptyline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00701	CcSEcCtD
Amitriptyline—KCNQ3—central nervous system—amyotrophic lateral sclerosis	0.000697	0.00609	CbGeAlD
Amitriptyline—DRD2—hindbrain—amyotrophic lateral sclerosis	0.000686	0.006	CbGeAlD
Amitriptyline—KCNQ3—cerebellum—amyotrophic lateral sclerosis	0.000681	0.00596	CbGeAlD
Amitriptyline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00676	CcSEcCtD
Amitriptyline—KCNQ2—nervous system—amyotrophic lateral sclerosis	0.000666	0.00582	CbGeAlD
Amitriptyline—KCNA1—spinal cord—amyotrophic lateral sclerosis	0.000656	0.00574	CbGeAlD
Amitriptyline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00651	CcSEcCtD
Amitriptyline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00648	CcSEcCtD
Amitriptyline—KCNQ2—central nervous system—amyotrophic lateral sclerosis	0.000641	0.00561	CbGeAlD
Amitriptyline—KCND2—nervous system—amyotrophic lateral sclerosis	0.000631	0.00552	CbGeAlD
Amitriptyline—KCNQ2—cerebellum—amyotrophic lateral sclerosis	0.000627	0.00548	CbGeAlD
Amitriptyline—KCND2—central nervous system—amyotrophic lateral sclerosis	0.000607	0.00531	CbGeAlD
Amitriptyline—HTR2A—nerve—amyotrophic lateral sclerosis	0.000604	0.00528	CbGeAlD
Amitriptyline—KCND2—cerebellum—amyotrophic lateral sclerosis	0.000593	0.00519	CbGeAlD
Amitriptyline—OPRM1—brainstem—amyotrophic lateral sclerosis	0.000589	0.00515	CbGeAlD
Amitriptyline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00588	CcSEcCtD
Amitriptyline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000579	0.0058	CcSEcCtD
Amitriptyline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00056	0.00561	CcSEcCtD
Amitriptyline—KCNQ3—brain—amyotrophic lateral sclerosis	0.000553	0.00484	CbGeAlD
Amitriptyline—KCNA1—nervous system—amyotrophic lateral sclerosis	0.000553	0.00483	CbGeAlD
Amitriptyline—KCND3—nervous system—amyotrophic lateral sclerosis	0.00055	0.00481	CbGeAlD
Amitriptyline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00542	CcSEcCtD
Amitriptyline—HTR1B—brainstem—amyotrophic lateral sclerosis	0.000539	0.00472	CbGeAlD
Amitriptyline—KCNA1—central nervous system—amyotrophic lateral sclerosis	0.000532	0.00465	CbGeAlD
Amitriptyline—KCND3—central nervous system—amyotrophic lateral sclerosis	0.000529	0.00463	CbGeAlD
Amitriptyline—CHRM4—nervous system—amyotrophic lateral sclerosis	0.000524	0.00458	CbGeAlD
Amitriptyline—HTR1D—brainstem—amyotrophic lateral sclerosis	0.000522	0.00457	CbGeAlD
Amitriptyline—KCNA1—cerebellum—amyotrophic lateral sclerosis	0.00052	0.00455	CbGeAlD
Amitriptyline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00052	0.00521	CcSEcCtD
Amitriptyline—KCND3—cerebellum—amyotrophic lateral sclerosis	0.000517	0.00452	CbGeAlD
Amitriptyline—HTR2C—brainstem—amyotrophic lateral sclerosis	0.000517	0.00452	CbGeAlD
Amitriptyline—Rash—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00517	CcSEcCtD
Amitriptyline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000515	0.00517	CcSEcCtD
Amitriptyline—Headache—Riluzole—amyotrophic lateral sclerosis	0.000512	0.00514	CcSEcCtD
Amitriptyline—KCNQ2—brain—amyotrophic lateral sclerosis	0.000509	0.00445	CbGeAlD
Amitriptyline—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.000504	0.00441	CbGeAlD
Amitriptyline—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00049	0.00429	CbGeAlD
Amitriptyline—DRD3—nervous system—amyotrophic lateral sclerosis	0.000487	0.00426	CbGeAlD
Amitriptyline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000486	0.00487	CcSEcCtD
Amitriptyline—KCND2—brain—amyotrophic lateral sclerosis	0.000482	0.00422	CbGeAlD
Amitriptyline—DRD3—central nervous system—amyotrophic lateral sclerosis	0.000469	0.0041	CbGeAlD
Amitriptyline—HTR6—nervous system—amyotrophic lateral sclerosis	0.000469	0.0041	CbGeAlD
Amitriptyline—OPRD1—nervous system—amyotrophic lateral sclerosis	0.000453	0.00396	CbGeAlD
Amitriptyline—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.000452	0.00396	CbGeAlD
Amitriptyline—HTR6—central nervous system—amyotrophic lateral sclerosis	0.000451	0.00395	CbGeAlD
Amitriptyline—OPRD1—central nervous system—amyotrophic lateral sclerosis	0.000436	0.00381	CbGeAlD
Amitriptyline—HTR1A—brainstem—amyotrophic lateral sclerosis	0.000435	0.00381	CbGeAlD
Amitriptyline—OPRK1—nervous system—amyotrophic lateral sclerosis	0.000434	0.0038	CbGeAlD
Amitriptyline—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.000431	0.00377	CbGeAlD
Amitriptyline—HRH2—nervous system—amyotrophic lateral sclerosis	0.000428	0.00375	CbGeAlD
Amitriptyline—KCNA1—brain—amyotrophic lateral sclerosis	0.000422	0.00369	CbGeAlD
Amitriptyline—KCND3—brain—amyotrophic lateral sclerosis	0.00042	0.00368	CbGeAlD
Amitriptyline—OPRK1—central nervous system—amyotrophic lateral sclerosis	0.000418	0.00365	CbGeAlD
Amitriptyline—HTR7—brainstem—amyotrophic lateral sclerosis	0.000416	0.00364	CbGeAlD
Amitriptyline—HRH2—central nervous system—amyotrophic lateral sclerosis	0.000413	0.00361	CbGeAlD
Amitriptyline—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000412	0.0036	CbGeAlD
Amitriptyline—CHRM5—nervous system—amyotrophic lateral sclerosis	0.000409	0.00358	CbGeAlD
Amitriptyline—OPRK1—cerebellum—amyotrophic lateral sclerosis	0.000408	0.00357	CbGeAlD
Amitriptyline—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.000401	0.00351	CbGeAlD
Amitriptyline—CHRM4—brain—amyotrophic lateral sclerosis	0.0004	0.0035	CbGeAlD
Amitriptyline—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.000394	0.00345	CbGeAlD
Amitriptyline—DRD2—brainstem—amyotrophic lateral sclerosis	0.000393	0.00344	CbGeAlD
Amitriptyline—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.000374	0.00327	CbGeAlD
Amitriptyline—DRD3—brain—amyotrophic lateral sclerosis	0.000372	0.00325	CbGeAlD
Amitriptyline—OPRM1—spinal cord—amyotrophic lateral sclerosis	0.000366	0.0032	CbGeAlD
Amitriptyline—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.000366	0.0032	CbGeAlD
Amitriptyline—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00036	0.00315	CbGeAlD
Amitriptyline—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00036	0.00315	CbGeAlD
Amitriptyline—HTR6—brain—amyotrophic lateral sclerosis	0.000358	0.00313	CbGeAlD
Amitriptyline—ORM1—spinal cord—amyotrophic lateral sclerosis	0.000358	0.00313	CbGeAlD
Amitriptyline—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.000352	0.00308	CbGeAlD
Amitriptyline—OPRD1—brain—amyotrophic lateral sclerosis	0.000346	0.00303	CbGeAlD
Amitriptyline—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000339	0.00297	CbGeAlD
Amitriptyline—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.000335	0.00293	CbGeAlD
Amitriptyline—OPRK1—brain—amyotrophic lateral sclerosis	0.000332	0.0029	CbGeAlD
Amitriptyline—HRH2—brain—amyotrophic lateral sclerosis	0.000327	0.00286	CbGeAlD
Amitriptyline—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.000321	0.00281	CbGeAlD
Amitriptyline—CHRM5—brain—amyotrophic lateral sclerosis	0.000313	0.00274	CbGeAlD
Amitriptyline—OPRM1—nervous system—amyotrophic lateral sclerosis	0.000309	0.0027	CbGeAlD
Amitriptyline—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.000305	0.00266	CbGeAlD
Amitriptyline—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000303	0.00265	CbGeAlD
Amitriptyline—ORM1—nervous system—amyotrophic lateral sclerosis	0.000301	0.00264	CbGeAlD
Amitriptyline—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000301	0.00263	CbGeAlD
Amitriptyline—OPRM1—central nervous system—amyotrophic lateral sclerosis	0.000297	0.0026	CbGeAlD
Amitriptyline—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00029	0.00254	CbGeAlD
Amitriptyline—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00029	0.00254	CbGeAlD
Amitriptyline—ADRA1B—brain—amyotrophic lateral sclerosis	0.000286	0.0025	CbGeAlD
Amitriptyline—HTR2A—embryo—amyotrophic lateral sclerosis	0.000283	0.00247	CbGeAlD
Amitriptyline—HTR1B—nervous system—amyotrophic lateral sclerosis	0.000282	0.00247	CbGeAlD
Amitriptyline—CHRM2—nervous system—amyotrophic lateral sclerosis	0.000281	0.00246	CbGeAlD
Amitriptyline—ADRA1D—brain—amyotrophic lateral sclerosis	0.00028	0.00245	CbGeAlD
Amitriptyline—HTR1D—nervous system—amyotrophic lateral sclerosis	0.000273	0.00239	CbGeAlD
Amitriptyline—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.000272	0.00238	CbGeAlD
Amitriptyline—HTR2C—nervous system—amyotrophic lateral sclerosis	0.000271	0.00237	CbGeAlD
Amitriptyline—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.000271	0.00237	CbGeAlD
Amitriptyline—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00027	0.00237	CbGeAlD
Amitriptyline—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.000263	0.0023	CbGeAlD
Amitriptyline—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.000261	0.00228	CbGeAlD
Amitriptyline—HTR2A—brainstem—amyotrophic lateral sclerosis	0.000259	0.00227	CbGeAlD
Amitriptyline—HTR7—spinal cord—amyotrophic lateral sclerosis	0.000259	0.00226	CbGeAlD
Amitriptyline—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.000257	0.00225	CbGeAlD
Amitriptyline—CHRM1—nervous system—amyotrophic lateral sclerosis	0.000256	0.00224	CbGeAlD
Amitriptyline—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000247	0.00216	CbGeAlD
Amitriptyline—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.000246	0.00215	CbGeAlD
Amitriptyline—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.00024	0.0021	CbGeAlD
Amitriptyline—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000236	0.00207	CbGeAlD
Amitriptyline—OPRM1—brain—amyotrophic lateral sclerosis	0.000236	0.00206	CbGeAlD
Amitriptyline—CHRM3—nervous system—amyotrophic lateral sclerosis	0.000229	0.002	CbGeAlD
Amitriptyline—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000228	0.00199	CbGeAlD
Amitriptyline—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000226	0.00198	CbGeAlD
Amitriptyline—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00022	0.00193	CbGeAlD
Amitriptyline—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000219	0.00192	CbGeAlD
Amitriptyline—HTR7—nervous system—amyotrophic lateral sclerosis	0.000218	0.00191	CbGeAlD
Amitriptyline—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000218	0.0019	CbGeAlD
Amitriptyline—HTR1B—brain—amyotrophic lateral sclerosis	0.000216	0.00189	CbGeAlD
Amitriptyline—CHRM2—brain—amyotrophic lateral sclerosis	0.000215	0.00188	CbGeAlD
Amitriptyline—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000214	0.00188	CbGeAlD
Amitriptyline—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000213	0.00186	CbGeAlD
Amitriptyline—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00021	0.00184	CbGeAlD
Amitriptyline—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00021	0.00183	CbGeAlD
Amitriptyline—HTR1D—brain—amyotrophic lateral sclerosis	0.000209	0.00183	CbGeAlD
Amitriptyline—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000208	0.00182	CbGeAlD
Amitriptyline—HTR2C—brain—amyotrophic lateral sclerosis	0.000207	0.00181	CbGeAlD
Amitriptyline—DRD2—nervous system—amyotrophic lateral sclerosis	0.000206	0.0018	CbGeAlD
Amitriptyline—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000205	0.00179	CbGeAlD
Amitriptyline—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000202	0.00177	CbGeAlD
Amitriptyline—ALB—brain—amyotrophic lateral sclerosis	0.000202	0.00177	CbGeAlD
Amitriptyline—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000198	0.00173	CbGeAlD
Amitriptyline—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000198	0.00173	CbGeAlD
Amitriptyline—SLC6A4—brain—amyotrophic lateral sclerosis	0.000196	0.00172	CbGeAlD
Amitriptyline—CHRM1—brain—amyotrophic lateral sclerosis	0.000195	0.00171	CbGeAlD
Amitriptyline—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000195	0.0017	CbGeAlD
Amitriptyline—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000194	0.0017	CbGeAlD
Amitriptyline—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00019	0.00166	CbGeAlD
Amitriptyline—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000185	0.00162	CbGeAlD
Amitriptyline—ABCB1—embryo—amyotrophic lateral sclerosis	0.000185	0.00162	CbGeAlD
Amitriptyline—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000181	0.00158	CbGeAlD
Amitriptyline—CHRM3—brain—amyotrophic lateral sclerosis	0.000175	0.00153	CbGeAlD
Amitriptyline—HTR1A—brain—amyotrophic lateral sclerosis	0.000174	0.00152	CbGeAlD
Amitriptyline—SLC6A2—brain—amyotrophic lateral sclerosis	0.000173	0.00151	CbGeAlD
Amitriptyline—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000167	0.00146	CbGeAlD
Amitriptyline—HTR7—brain—amyotrophic lateral sclerosis	0.000167	0.00146	CbGeAlD
Amitriptyline—HRH1—nervous system—amyotrophic lateral sclerosis	0.000163	0.00142	CbGeAlD
Amitriptyline—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000161	0.00141	CbGeAlD
Amitriptyline—ADRA1A—brain—amyotrophic lateral sclerosis	0.000161	0.0014	CbGeAlD
Amitriptyline—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00016	0.0014	CbGeAlD
Amitriptyline—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00016	0.0014	CbGeAlD
Amitriptyline—DRD2—brain—amyotrophic lateral sclerosis	0.000157	0.00138	CbGeAlD
Amitriptyline—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000157	0.00137	CbGeAlD
Amitriptyline—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000156	0.00137	CbGeAlD
Amitriptyline—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000154	0.00135	CbGeAlD
Amitriptyline—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00015	0.00132	CbGeAlD
Amitriptyline—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00015	0.00132	CbGeAlD
Amitriptyline—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000147	0.00129	CbGeAlD
Amitriptyline—CYP2C8—brain—amyotrophic lateral sclerosis	0.000142	0.00124	CbGeAlD
Amitriptyline—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000136	0.00119	CbGeAlD
Amitriptyline—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000131	0.00114	CbGeAlD
Amitriptyline—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000128	0.00112	CbGeAlD
Amitriptyline—CYP2B6—brain—amyotrophic lateral sclerosis	0.000127	0.00111	CbGeAlD
Amitriptyline—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000126	0.0011	CbGeAlD
Amitriptyline—HRH1—brain—amyotrophic lateral sclerosis	0.000124	0.00109	CbGeAlD
Amitriptyline—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000124	0.00108	CbGeAlD
Amitriptyline—ADRA2A—brain—amyotrophic lateral sclerosis	0.000122	0.00107	CbGeAlD
Amitriptyline—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000121	0.00106	CbGeAlD
Amitriptyline—CYP2E1—brain—amyotrophic lateral sclerosis	0.000119	0.00104	CbGeAlD
Amitriptyline—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000119	0.00104	CbGeAlD
Amitriptyline—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000118	0.00104	CbGeAlD
Amitriptyline—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000116	0.00102	CbGeAlD
Amitriptyline—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000106	0.000924	CbGeAlD
Amitriptyline—HTR2A—brain—amyotrophic lateral sclerosis	0.000104	0.000908	CbGeAlD
Amitriptyline—CYP2D6—brain—amyotrophic lateral sclerosis	9.46e-05	0.000827	CbGeAlD
Amitriptyline—ABCB1—nervous system—amyotrophic lateral sclerosis	8.9e-05	0.000779	CbGeAlD
Amitriptyline—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.57e-05	0.00075	CbGeAlD
Amitriptyline—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.38e-05	0.000733	CbGeAlD
Amitriptyline—ABCB1—brain—amyotrophic lateral sclerosis	6.8e-05	0.000595	CbGeAlD
Amitriptyline—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.84e-06	9.43e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.78e-06	9.35e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.76e-06	9.33e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.7e-06	9.26e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.68e-06	9.23e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.67e-06	9.22e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.63e-06	9.18e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.62e-06	9.16e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.61e-06	9.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.59e-06	9.13e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.57e-06	9.1e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.56e-06	9.09e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.56e-06	9.09e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.52e-06	9.05e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.5e-06	9.01e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.48e-06	8.99e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	7.47e-06	8.98e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.46e-06	8.96e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.32e-06	8.8e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.29e-06	8.77e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.28e-06	8.76e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.28e-06	8.75e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.28e-06	8.75e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.27e-06	8.74e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.21e-06	8.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.21e-06	8.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.2e-06	8.66e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.17e-06	8.62e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.14e-06	8.58e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.11e-06	8.55e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.07e-06	8.5e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.02e-06	8.44e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.95e-06	8.35e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.82e-06	8.2e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.82e-06	8.19e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.78e-06	8.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.77e-06	8.14e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.72e-06	8.07e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.71e-06	8.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.71e-06	8.07e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.68e-06	8.03e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.68e-06	8.03e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.68e-06	8.03e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.67e-06	8.01e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.64e-06	7.98e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.63e-06	7.97e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.56e-06	7.88e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.54e-06	7.86e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.53e-06	7.85e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.53e-06	7.85e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.52e-06	7.84e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.52e-06	7.84e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.5e-06	7.81e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.48e-06	7.79e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.48e-06	7.79e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.42e-06	7.71e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.4e-06	7.69e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.35e-06	7.63e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.29e-06	7.55e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.27e-06	7.53e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.25e-06	7.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.24e-06	7.51e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.19e-06	7.45e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.16e-06	7.41e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.14e-06	7.38e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.14e-06	7.38e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.13e-06	7.37e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.13e-06	7.36e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.11e-06	7.35e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.09e-06	7.32e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.03e-06	7.25e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.02e-06	7.23e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6e-06	7.21e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	5.99e-06	7.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.99e-06	7.19e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.94e-06	7.15e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.9e-06	7.09e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.85e-06	7.03e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.82e-06	7e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.82e-06	6.99e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.78e-06	6.95e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.77e-06	6.94e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.77e-06	6.93e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.74e-06	6.9e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.6e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.59e-06	6.72e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.57e-06	6.7e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.56e-06	6.69e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.55e-06	6.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.55e-06	6.67e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	5.53e-06	6.65e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.52e-06	6.63e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	5.5e-06	6.61e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.5e-06	6.61e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.47e-06	6.57e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.43e-06	6.53e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.42e-06	6.52e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.42e-06	6.51e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.4e-06	6.49e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.38e-06	6.47e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.33e-06	6.41e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.32e-06	6.39e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.31e-06	6.38e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.28e-06	6.34e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	5.16e-06	6.2e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.15e-06	6.19e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.14e-06	6.18e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.1e-06	6.13e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.05e-06	6.08e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	5.05e-06	6.07e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.04e-06	6.06e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	5.04e-06	6.06e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.03e-06	6.05e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.03e-06	6.04e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.03e-06	6.04e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.02e-06	6.04e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.01e-06	6.02e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.99e-06	6e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.96e-06	5.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.95e-06	5.95e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.94e-06	5.94e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.94e-06	5.94e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.94e-06	5.93e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.89e-06	5.87e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.83e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.82e-06	5.79e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.81e-06	5.78e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.75e-06	5.71e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.75e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.74e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.74e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.74e-06	5.69e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.72e-06	5.67e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.7e-06	5.65e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.67e-06	5.61e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.62e-06	5.56e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.62e-06	5.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.6e-06	5.53e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.6e-06	5.53e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.54e-06	5.46e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.48e-06	5.39e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	4.37e-06	5.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.37e-06	5.25e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.36e-06	5.24e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.34e-06	5.22e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.33e-06	5.2e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.32e-06	5.19e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.31e-06	5.18e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.29e-06	5.16e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.27e-06	5.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.27e-06	5.13e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.27e-06	5.13e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.26e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.25e-06	5.1e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.23e-06	5.09e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.2e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.18e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.17e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.15e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.15e-06	4.98e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.14e-06	4.98e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.11e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.1e-06	4.93e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.09e-06	4.92e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.07e-06	4.9e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.04e-06	4.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.04e-06	4.85e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.02e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.02e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.9e-06	4.68e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.85e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.8e-06	4.57e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.8e-06	4.57e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.77e-06	4.53e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.73e-06	4.48e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.72e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.7e-06	4.45e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.69e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.66e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.62e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.62e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.58e-06	4.31e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.55e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.54e-06	4.26e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.53e-06	4.25e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.52e-06	4.23e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.5e-06	4.21e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.46e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.45e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.35e-06	4.03e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.27e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.27e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.22e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.22e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.22e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.21e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.2e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.2e-06	3.84e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.19e-06	3.83e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.16e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.16e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.15e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.14e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.13e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.1e-06	3.73e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.09e-06	3.71e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.04e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.04e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.04e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.03e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.02e-06	3.63e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.01e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.01e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.99e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.98e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.98e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.97e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.93e-06	3.52e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.91e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.85e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.77e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.76e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.76e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.74e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.74e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.73e-06	3.28e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.72e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.71e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.71e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.68e-06	3.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.67e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.67e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.61e-06	3.13e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.48e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.46e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.43e-06	2.93e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.39e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.37e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.34e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.27e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.1e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.08e-06	2.5e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.06e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.06e-06	2.47e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.05e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.04e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.02e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.02e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.88e-06	2.25e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.61e-06	1.93e-05	CbGpPWpGaD
